NASDAQ: ELEVElevation Oncology Inc Stock Ownership - Who owns Elevation Oncology?
Insider buying vs selling
Have Elevation Oncology Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Tammy Furlong | CHIEF FINANCIAL OFFICER | 2025-05-15 | 784 | $0.30 | $235.20Sell |
| Joseph J. Ferra Jr. | CHIEF EXECUTIVE OFFICER | 2025-05-15 | 2,303 | $0.30 | $690.90Sell |
| Joseph J. Ferra Jr. | CHIEF EXECUTIVE OFFICER | 2025-03-16 | 4,628 | $0.53 | $2.47kSell |
| Valerie Malyvanh Jansen | CHIEF MEDICAL OFFICER | 2025-02-15 | 5,189 | $0.67 | $3.49kSell |
| Joseph J. Ferra Jr. | CHIEF EXECUTIVE OFFICER | 2025-02-15 | 9,211 | $0.67 | $6.19kSell |
| Tammy Furlong | CHIEF FINANCIAL OFFICER | 2025-02-15 | 2,780 | $0.67 | $1.87kSell |
| Tammy Furlong | CHIEF FINANCIAL OFFICER | 2025-02-15 | 89 | $0.67 | $59.81Sell |
| David Dornan | CHIEF SCIENTIFIC OFFICER | 2025-02-15 | 4,152 | $0.67 | $2.79kSell |
| Joseph J. Ferra Jr. | CHIEF EXECUTIVE OFFICER | 2024-12-16 | 4,629 | $0.64 | $2.96kSell |
| Tammy Furlong | CHIEF FINANCIAL OFFICER | 2024-11-15 | 98 | $0.53 | $52.04Sell |
ELEV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ELEV insiders and whales buy or sell their stock.
ELEV Shareholders
What type of owners hold Elevation Oncology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Frazier Life Sciences Management LP | 10.12% | 5,993,579 | $2.29M | Institution |
| Bml Capital Management LLC | 9.95% | 5,890,934 | $2.25M | Institution |
| Tang Capital Management LLC | 8.04% | 4,760,000 | $1.82M | Institution |
| Blackrock Inc | 5.37% | 3,177,903 | $1.21M | Institution |
| Aisling Capital IV LP | 4.79% | 2,834,910 | $1.08M | Insider |
| Aisling Capital Management LP | 4.79% | 2,834,910 | $1.08M | Institution |
| Vanguard Group Inc | 4.37% | 2,585,220 | $987.55k | Institution |
| Qiming Us Healthcare Fund II LP | 4.00% | 2,370,142 | $905.39k | Insider |
| Vertex Global Hc Fund II Pte Ltd | 3.90% | 2,307,642 | $881.52k | Insider |
| Cormorant Asset Management LP | 3.77% | 2,233,168 | $853.07k | Insider |
ELEV vs Biotech Stocks
Elevation Oncology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.